Vascular Endothelial Growth Factor B (VEGF Related Factor or VEGFB) Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Vascular Endothelial Growth Factor B also known as VEGFB is a protein encoded by the VEGF-B gene. It regulates the formation of blood vessels and is involved in endothelial cell physiology. It is a ligand for VEGFR-1 (vascular endothelial growth factor receptor 1) and NRP-1 (neuropilin-1).
The Vascular Endothelial Growth Factor – Drugs in Development research report provides a comprehensive overview on the therapeutics under development for Vascular Endothelial Growth Factor, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Vascular Endothelial Growth Factor and features dormant and discontinued projects.
Key Therapy Areas in the Vascular Endothelial Growth Factor B Pipeline Drugs Market
The key therapy areas in the Vascular Endothelial Growth Factor B Pipeline drugs market are Oncology, Ophthalmology, and Metabolic Disorders.
Vascular Endothelial Growth Factor B Pipeline Drugs Market, by Therapy Areas
For more target insights, download a free report sample
Key MoA in the Vascular Endothelial Growth Factor B Pipeline Drugs Market
The key mechanisms of action in the Vascular Endothelial Growth Factor B Pipeline drugs market are Vascular endothelial growth factor B Inhibitor, Placenta Growth Factor Inhibitor, and Vascular Endothelial Growth Factor A Inhibitor.
Vascular Endothelial Growth Factor B Pipeline Drugs Market, by MoA
To get more insights on key MoA, download a free sample report
Vascular Endothelial Growth Factor B Pipeline Drugs Market Segmentation by RoA
The key routes of administration in the Vascular Endothelial Growth Factor B Pipeline drugs market are Subcutaneous, Intravenous, and Intravitreal.
Vascular Endothelial Growth Factor B Pipeline Drugs Market Analysis, by RoA
To get more insights on key RoA, download a free sample report
Key Molecule Types in the Vascular Endothelial Growth Factor B Pipeline Drugs Market
The key molecule types in the Vascular Endothelial Growth Factor B Pipeline drugs market are Monoclonal Antibody, and Fusion Protein.
Vascular Endothelial Growth Factor B Pipeline Drugs Market Analysis, by Molecule
For more company insights, download a free sample report
Major Companies in the Vascular Endothelial Growth Factor B Pipeline Drugs Market
The major companies in the Vascular Endothelial Growth Factor B Pipeline drugs market are Alvotech ehf, CSL Ltd, GlycoNex Inc, Luye Pharma Group Ltd, Panolos Bioscie, Regeneron Pharmaceuticals Inc, Prestige BioPharma Ltd, Mabwell Shanghai Bioscience Co Ltd and Rophibio Inc among others.
Vascular Endothelial Growth Factor B Pipeline Drugs Market, by Major Companies
For more company insights, download a free sample report
Vascular Endothelial Growth Factor B Pipeline Drugs Market Overview
Key Therapy Areas | Oncology, Ophthalmology, and Metabolic Disorders |
Key Mechanisms of action | Vascular Vascular Vascular endothelial growth factor B Inhibitor, Placenta Growth Factor Inhibitor, and Vascular Endothelial Growth Factor A Inhibitor |
Key Routes of Administration | Subcutaneous, Intravenous, and Intravitreal |
Key molecule types | Monoclonal Antibody, and Fusion Protein |
Major companies | Alvotech ehf, CSL Ltd, GlycoNex Inc, Luye Pharma Group Ltd, Panolos Bioscie, Regeneron Pharmaceuticals Inc, Prestige BioPharma Ltd, Mabwell Shanghai Bioscience Co Ltd and Rophibio Inc |
Scope
- The pipeline guide provides a snapshot of the global therapeutic landscape of Vascular Endothelial Growth Factor
- The pipeline guide reviews pipeline therapeutics for Vascular endothelial growth factor By companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Vascular Endothelial Growth Factor therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Endothelial Growth Factor therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA), and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews the latest news related to pipeline therapeutics for Vascular Endothelial Growth Factor
Reasons to Buy
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with a potentially strong product portfolio and create effective counter strategies to gain a competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Vascular Endothelial Growth Factor
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and their most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Vascular Endothelial Growth Factor B Pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from the pipeline.
CSL Ltd
GlycoNex Inc
Luye Pharma Group Ltd
Mabwell Shanghai Bioscience Co Ltd
Panolos Bioscience
Prestige BioPharma Ltd
Regeneron Pharmaceuticals Inc
Rophibio Inc
Table of Contents
Table
Figures
Frequently asked questions
-
What are the key therapy areas in the Vascular Endothelial Growth Factor B Pipeline drugs market?
The key targets in the Vascular Endothelial Growth Factor B Pipeline drugs market are Oncology, Ophthalmology, and Metabolic Disorders.
-
What are the key mechanisms of action in the Vascular Endothelial Growth Factor B Pipeline drugs market?
The key mechanisms of action in the Vascular Endothelial Growth Factor B Pipeline drugs market are Vascular endothelial growth factor B Inhibitor, Placenta Growth Factor Inhibitor, and Vascular Endothelial Growth Factor A Inhibitor.
-
What are the key routes of administration in the Vascular Endothelial Growth Factor B Pipeline drugs market?
The key routes of administration in the Vascular Endothelial Growth Factor B Pipeline drugs market are Subcutaneous, Intravenous, and Intravitreal.
-
What are the key molecule types in the Vascular Endothelial Growth Factor B Pipeline drugs market?
The key molecule types in the Vascular Endothelial Growth Factor B Pipeline drugs market are Monoclonal Antibody, and Fusion Protein.
-
What are the major companies in the Vascular Endothelial Growth Factor B Pipeline drugs market?
The major companies in the Vascular Endothelial Growth Factor B Pipeline drugs market are Alvotech ehf, CSL Ltd, GlycoNex Inc, Luye Pharma Group Ltd, Panolos Bioscie, Regeneron Pharmaceuticals Inc, Prestige BioPharma Ltd, Mabwell Shanghai Bioscience Co Ltd and Rophibio Inc.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.